Single extracellular vesicle analysis for early cancer detection.

cancer early detection exosome extracellular vesicle

Journal

Trends in molecular medicine
ISSN: 1471-499X
Titre abrégé: Trends Mol Med
Pays: England
ID NLM: 100966035

Informations de publication

Date de publication:
08 2022
Historique:
received: 04 03 2022
revised: 02 05 2022
accepted: 03 05 2022
pubmed: 28 5 2022
medline: 3 8 2022
entrez: 27 5 2022
Statut: ppublish

Résumé

Extracellular vesicles (EVs) are actively shed into the circulation from both cancer and host cells. EVs are emerging as one of the diagnostic frontrunners for early cancer detection, disease monitoring, and treatment evaluation. The advantages of EVs rely on the fact that vesicles are being shed by dividing tumor cells, with indications that human and viral oncogenes, cellular metabolic rate, and tumor characteristics such as pH and hypoxia contribute to the high shed rates in cancer. In this review, we provide an overview of EVs and the rationale for using them for early cancer detection. We examine emerging technologies for single EV analysis (sEVA) and why these technologies will be necessary for early cancer detection.

Identifiants

pubmed: 35624008
pii: S1471-4914(22)00111-3
doi: 10.1016/j.molmed.2022.05.003
pmc: PMC9339504
mid: NIHMS1817131
pii:
doi:

Types de publication

Journal Article Review Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

681-692

Subventions

Organisme : NCI NIH HHS
ID : P01 CA069246
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA079443
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA237332
Pays : United States
Organisme : NCI NIH HHS
ID : R21 CA236561
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA204019
Pays : United States

Informations de copyright

Copyright © 2022. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of interests R.W. is a consultant to ModeRNA, Tarveda Therapeutics, Lumicell, Seer, Earli, Aikili Biosystems, and Accure Health.

Références

Cancer Cell. 2017 Aug 14;32(2):238-252.e9
pubmed: 28810146
Small. 2016 Jun;12(24):3292-301
pubmed: 27171437
Sci Rep. 2019 Mar 29;9(1):5335
pubmed: 30926864
Adv Biosyst. 2020 Dec;4(12):e1900305
pubmed: 32394646
PLoS One. 2018 Sep 27;13(9):e0204276
pubmed: 30260987
J Extracell Vesicles. 2021 Jan;10(3):e12047
pubmed: 33456726
J Proteome Res. 2008 Dec;7(12):5157-66
pubmed: 19367702
Clin Cancer Res. 2020 Jul 1;26(13):3248-3258
pubmed: 32299821
Adv Biosyst. 2020 Dec;4(12):e1900307
pubmed: 33274611
Cancers (Basel). 2021 Aug 31;13(17):
pubmed: 34503207
Adv Drug Deliv Rev. 2021 Sep;176:113872
pubmed: 34284058
Proc Natl Acad Sci U S A. 2021 Sep 21;118(38):
pubmed: 34518226
Blood. 2021 Jun 10;137(23):3174-3180
pubmed: 33940594
Cancer Res. 2018 Jul 1;78(13):3407-3412
pubmed: 29921699
Eur Biophys J. 2017 Dec;46(8):813-820
pubmed: 28866771
Ann Oncol. 2018 Dec 1;29(12):2379-2383
pubmed: 30339193
Science. 2018 Feb 23;359(6378):926-930
pubmed: 29348365
ACS Nano. 2020 Nov 24;14(11):14528-14548
pubmed: 33119256
Cancer Res. 2018 Jul 1;78(13):3688-3697
pubmed: 29735554
Anal Chem. 2020 Apr 21;92(8):6010-6018
pubmed: 32207920
J Extracell Vesicles. 2014 Mar 25;3:
pubmed: 24678386
J Cell Biol. 2013 Feb 18;200(4):373-83
pubmed: 23420871
Mol Oncol. 2021 Jun;15(6):1727-1743
pubmed: 33219615
Gastroenterology. 2021 Mar;160(4):1345-1358.e11
pubmed: 33301777
J Cell Sci. 2005 Jul 1;118(Pt 13):2849-58
pubmed: 15976444
J Extracell Vesicles. 2019 Nov 4;8(1):1685634
pubmed: 31741725
Sci Rep. 2017 May 12;7(1):1878
pubmed: 28500324
Nat Rev Mol Cell Biol. 2018 Apr;19(4):213-228
pubmed: 29339798
J Cell Sci. 2013 Dec 15;126(Pt 24):5553-65
pubmed: 24105262
Ann Oncol. 2017 Apr 1;28(4):741-747
pubmed: 28104621
J Neurooncol. 2013 May;113(1):1-11
pubmed: 23456661
Nano Lett. 2018 Jul 11;18(7):4226-4232
pubmed: 29888919
Theranostics. 2022 Jan 31;12(5):1988-1998
pubmed: 35265194
Nat Biotechnol. 2014 May;32(5):490-5
pubmed: 24752081
ACS Appl Mater Interfaces. 2016 Oct 5;8(39):25825-25833
pubmed: 27617891
Sci Transl Med. 2018 Mar 21;10(433):
pubmed: 29563323
J Extracell Vesicles. 2013 Jan 10;2:
pubmed: 24009896
ACS Nano. 2021 Jun 28;:
pubmed: 34181396
Nanomedicine. 2018 Apr;14(3):875-882
pubmed: 29288729
Sci Transl Med. 2014 Feb 19;6(224):224ra24
pubmed: 24553385
J Thromb Haemost. 2010 Dec;8(12):2596-607
pubmed: 20880256
Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):14888-93
pubmed: 25267620
Cancer Biol Ther. 2017 Mar 4;18(3):158-165
pubmed: 28121262
Sci Rep. 2020 Jan 23;10(1):1039
pubmed: 31974468
J Am Chem Soc. 2019 Mar 6;141(9):3817-3821
pubmed: 30789261
Biomed Microdevices. 2020 Mar 11;22(2):23
pubmed: 32162067
Sens Actuators Rep. 2021 Nov;3:
pubmed: 35098157
ACS Nano. 2021 Mar 23;15(3):5631-5638
pubmed: 33687214
Cancer Cell. 2016 Dec 12;30(6):836-848
pubmed: 27960084
J Cell Sci. 2010 May 15;123(Pt 10):1603-11
pubmed: 20445011
Langmuir. 2011 Dec 6;27(23):14394-400
pubmed: 22017459
J Hepatol. 2017 Aug;67(2):282-292
pubmed: 28267620
J Extracell Vesicles. 2020 Aug 26;9(1):1809765
pubmed: 32944195
Neoplasia. 2021 Jan;23(1):149-157
pubmed: 33321449
Sci Adv. 2022 Apr 22;8(16):eabm3453
pubmed: 35452280
Nat Commun. 2017 Oct 26;8(1):1145
pubmed: 29074968
Nanomedicine. 2017 Apr;13(3):835-841
pubmed: 27965168
Nat Commun. 2021 May 31;12(1):3246
pubmed: 34059690
Nat Cell Biol. 2019 Jan;21(1):9-17
pubmed: 30602770
Cells. 2020 Mar 09;9(3):
pubmed: 32182815
Angew Chem Int Ed Engl. 2020 Apr 20;59(17):6839-6846
pubmed: 32004403
J Cell Biol. 2018 Mar 5;217(3):1129-1142
pubmed: 29339438
ACS Nano. 2018 Jan 23;12(1):671-680
pubmed: 29300458
Science. 2020 Jul 3;369(6499):
pubmed: 32345712
Cell. 2020 Aug 20;182(4):1044-1061.e18
pubmed: 32795414
Chem Rev. 2018 Feb 28;118(4):1917-1950
pubmed: 29384376
Cell Mol Neurobiol. 2016 Apr;36(3):301-12
pubmed: 27053351
Oncoimmunology. 2021 Oct 29;10(1):1995166
pubmed: 34745768
Annu Rev Cell Dev Biol. 2014;30:255-89
pubmed: 25288114
Theranostics. 2019 Jun 9;9(15):4494-4507
pubmed: 31285775
Front Immunol. 2018 Apr 30;9:738
pubmed: 29760691
Cancers (Basel). 2019 Aug 02;11(8):
pubmed: 31382533
Methods Mol Biol. 2017;1545:43-54
pubmed: 27943206
J Extracell Vesicles. 2015 Jul 17;4:27031
pubmed: 26194179
Sci Rep. 2016 Apr 18;6:24316
pubmed: 27087061
Cell Mol Life Sci. 2011 Aug;68(16):2667-88
pubmed: 21560073
Science. 2016 Apr 8;352(6282):242-6
pubmed: 26989197
CA Cancer J Clin. 2021 Jul;71(4):333-358
pubmed: 33982817
ACS Nano. 2018 Jan 23;12(1):494-503
pubmed: 29286635
Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18392-7
pubmed: 20930119
Nat Cell Biol. 2021 Jun;23(6):631-641
pubmed: 34108659
Cancer Discov. 2012 Dec;2(12):1150-65
pubmed: 22896036
Gastroenterology. 2019 Jan;156(1):108-118.e4
pubmed: 30240661
PLoS One. 2016 Jan 08;11(1):e0144678
pubmed: 26745887

Auteurs

Scott Ferguson (S)

Center for Systems Biology, Massachusetts General Hospital, 185 Cambridge St, CPZN 5206, Boston, MA 02114, USA.

Katherine S Yang (KS)

Center for Systems Biology, Massachusetts General Hospital, 185 Cambridge St, CPZN 5206, Boston, MA 02114, USA.

Ralph Weissleder (R)

Center for Systems Biology, Massachusetts General Hospital, 185 Cambridge St, CPZN 5206, Boston, MA 02114, USA; Department of Systems Biology, Harvard Medical School, 200 Longwood Ave, Boston, MA 02115, USA. Electronic address: rweissleder@mgh.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH